Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
InChiKey: XYWJNTOURDMTPI-UHFFFAOYSA-N
C[C@H]1CNCCCN1S(=O)(=O)C1=CC=CC2=CN=CC(F)=C21
PPARα and-γ
PubMed PMID: 19299584
3-difluoro-1-methylpiperidin-4-yl]oxy}-N-(3-ethynyl-2-fluorophenyl)-7-methoxyquinazolin-4-amine
Oritavancin(LY-333328) 18655 InChiKey: XYWJNTOURDMTPI-UHFFFAOYSA-NOritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci. Product information CAS Number: 171099 57 3 Molecular Weight: 1748. 06 Formula:
US$ 44.99
US$ 39.00
US$ 29.99
US$ 29.99